Moreover, the frequency of Tet+ CD8+ T cells remained higher in the CX3CR1+ subset than in the CX3CR1− subsets in both tumor models (Fig. 3c), suggesting that the PB CX3CR1+ subset is enriched with tumor-specific CD8+ T cells. This evidence concerns the gene CD8A and neoplasm.